{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Gestational Trophoblastic Disease: Current Evaluation and Management *6155*

Activity Steps

Description

Cognate Code 6155

Learning Objectives

After completing this continuing education activity you will be able to:

  1. List the current guidelines from the International Federation of Gynecology and Obstetrics (FIGO) for making the diagnosis.
  2. Outline the steps in management for patients with gestational trophoblastic disease.
  3. Discuss the treatment and surveillance of patients with hydatidiform mole.
  4. Institute a plan of care for those who develop trophoblastic neoplasia.
Price: $25.00

Credits:

  • ACOG 2.0 CME

The American College of Obstetricians and Gynecologists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credit(s) The American College of Obstetricians and Gynecologists designates this journal-based activity for a maximum of 2 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

College Cognate Credit(s) The American College of Obstetricians and Gynecologists designates this journal-based activity for a maximum of 2 Category 1 College Cognate Credits. The College has a reciprocity agreement with the AMA that allows AMA PRA Category 1 Credits TM to be equivalent to College Cognate Credits.

Professions: Physician
Test Code: ONG0121
Published: January 7, 2021
Expires: 2/29/2024
Required Passing Score: 7/10 (70%)
Authors: John T. Soper, MD
Specialties: OB/GYN